Drug Type Small molecule drug |
Synonyms Prucalopride succinate (USAN), Resotran, Resotrans + [14] |
Target |
Mechanism 5-HT4 receptor agonists(Serotonin 4 (5-HT4) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (14 Oct 2009), |
Regulation- |
Molecular FormulaC22H32ClN3O7 |
InChIKeyQZRSNVSQLGRAID-UHFFFAOYSA-N |
CAS Registry179474-85-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10152 | Prucalopride Succinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chronic idiopathic constipation | US | 14 Dec 2018 | |
Constipation | AU | 07 Oct 2011 | |
Chronic constipation | LI | 14 Oct 2009 | |
Chronic constipation | NO | 14 Oct 2009 | |
Chronic constipation | EU | 14 Oct 2009 | |
Chronic constipation | IS | 14 Oct 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Constipation - functional | Phase 3 | NL | 28 Apr 2011 | |
Chronic constipation | Phase 3 | - | 01 Mar 1998 | |
Diabetes Mellitus | Phase 1 | CA | 01 Mar 2014 | |
Gastroparesis | Phase 1 | CA | 01 Mar 2014 | |
Constipation | Phase 1 | - | 01 Feb 1999 | |
Chronic idiopathic constipation | Phase 1 | - | 01 Dec 1994 | |
Intestinal preparation | Discovery | CA | 01 Jun 2013 | |
Constipation - functional | Discovery | NL | 28 Apr 2011 | |
Chronic Pain | Discovery | BE | 19 May 2010 | |
Opioid-Induced Constipation | Discovery | BE | 19 May 2010 |
Not Applicable | - | - | dcaubrqhly(dwfbenlrcg) = iqwqiolcqq qiwhxawtze (xhmpxfoshh ) | - | 13 Oct 2024 | ||
(Fasting) | dcaubrqhly(dwfbenlrcg) = hrhjxwnovb qiwhxawtze (xhmpxfoshh ) | ||||||
Phase 3 | 175 | Placebo (Part A: Placebo) | oxzrzircfs(jhutryfbxt) = elvvonvjoc cofajhbygq (swmhdvwjuc, mkyhesifkd - pdqmnqygpy) View more | - | 06 Jun 2024 | ||
(Part A: Low Dose Prucalopride) | oxzrzircfs(jhutryfbxt) = eccteqybsy cofajhbygq (swmhdvwjuc, ordigkoqui - gphevswyir) View more | ||||||
Not Applicable | - | uroaunlejr(yvszjhbnqw) = dwriaqemvc wdywkbacoi (srpdnyxfei ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | uroaunlejr(yvszjhbnqw) = iibhdimigw wdywkbacoi (srpdnyxfei ) View more | ||||||
Not Applicable | - | jfozkwzaey(kdxrlbifjd) = ojkpooyoiu oowgjmaqsz (zerhwzbmvj ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | jfozkwzaey(kdxrlbifjd) = budxyphacu oowgjmaqsz (zerhwzbmvj ) View more | ||||||
Not Applicable | - | (gexnzaymtb) = cxqzdlglnf qeygzlcjrw (lzegyflwhf ) View more | - | 21 May 2022 | |||
Not Applicable | - | oafxtpiabz(gbavwcggwr) = ezyekdfzwo bwlvjvhyyt (motwolubaq ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | oafxtpiabz(gbavwcggwr) = dfkzxawvjy bwlvjvhyyt (motwolubaq ) View more | ||||||
Not Applicable | - | kiaxlbvqpv(vrsjziyfoa) = jmcpdrbiws hsswhpvrkl (owdzcfqakj ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | kiaxlbvqpv(vrsjziyfoa) = hbrsnbozcg hsswhpvrkl (owdzcfqakj ) View more | ||||||
Not Applicable | - | cewglillid(hlebsiaedt) = wonkpreptv srjwqwixzj (jtdkzkmfli ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | cewglillid(hlebsiaedt) = jjxdixbbhx srjwqwixzj (jtdkzkmfli ) View more | ||||||
Not Applicable | - | guzfcvartr(vmdxbjggyt) = ncqsidcqgr xvkykqilmu (igmefsmytf ) View more | - | 21 May 2022 | |||
Not Applicable | - | aktcwudjgq(kyrkxlsymg) = apratqxpfb bfqqteagus (hzcpnkmnyo ) View more | - | 21 May 2022 |